分化型甲状腺癌前缘免疫浸润特征分析
对17例分化型甲状腺癌(DTC)患者甲状腺切除标本行多重免疫荧光,比较肿瘤与癌旁组织的免疫标志物表达并分析肿瘤前缘空间分布。肿瘤内PD-1和PD-L1表达较癌旁组织显著升高(p<0.05),M2巨噬细胞呈升高趋势。远处转移组(n=3)较无转移组(n=14)肿瘤内FOXP3呈非显著升高趋势、CD8和iNOS呈非显著降低趋势。
要点
- 肿瘤内PD-1和PD-L1表达较癌旁组织显著升高(p<0.05)。
- 肿瘤前缘PD-L1表达与CD45负相关、与CD163正相关。
- 远处转移组肿瘤内FOXP3呈非显著升高趋势、CD8和iNOS呈非显著降低趋势。
核心结论
- 肿瘤内PD-1和PD-L1表达升高提示其在DTC发生中发挥作用。
- 远处转移性DTC患者肿瘤内Tregs和M2巨噬细胞增多、M1巨噬细胞减少的趋势提示其可能作为预后生物标志物。
- 需要更大样本量的未来研究比较不同临床病理严重程度,以利用肿瘤微环境进行癌症预后判断和治疗。
研究设计与样本
- 对17例成人DTC患者甲状腺切除时采集的石蜡包埋甲状腺组织行多重免疫荧光。
- 表征肿瘤免疫微环境中的白细胞(CD45+)、T细胞(CD3+)、调节性T细胞(Tregs)(CD3+FOXP3+)、CD4+ T细胞(CD3+CD4+)、CD8+ T细胞(CD3+CD8+)、巨噬细胞(CD68+)、M2巨噬细胞(CD68+CD163+)、M1巨噬细胞(CD68+诱导型一氧化氮合酶[iNOS]+)及免疫检查点PD-1和PD-L1。
- 采用配对t检验比较同一患者肿瘤与癌旁甲状腺组织的免疫标志物平均百分比表达,并沿肿瘤前缘进行空间分析。
主要发现
- 免疫检查点PD-1和PD-L1在肿瘤内的表达较癌旁甲状腺组织显著升高(p<0.05)。
- 肿瘤内M2巨噬细胞较癌旁组织呈升高趋势。
- 沿肿瘤前缘,PD-L1表达在肿瘤内与CD45负相关、与CD163正相关。
- 探索性分析中,有远处转移的DTC(n=3)较无远处转移者(n=14)肿瘤内FOXP3呈非显著升高趋势、CD8和iNOS呈非显著降低趋势。
- 有甲状腺炎者(n=7)较无甲状腺炎者(n=10)CD58和iNOS表达呈非显著升高趋势。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要更大样本量的未来研究比较不同临床病理严重程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Although the impact of tumor-immune infiltrate has been reported on differentiated thyroid cancer (DTC) behavior, the expression of immune checkpoints [programmed cell death protein 1 (PD-1) and its ligand (PD-L1)] alone has not been able to predict response to immunotherapies. We aimed to identify tumor-infiltrating immune cells and checkpoints associated with DTC. Methods: We performed multiplex immunofluorescence on deparaffinized thyroid tissue collected at thyroidectomy from 17 adults with DTC to characterize the tumor immune microenvironment for leukocytes (CD45+), T cells (CD3+), T regulatory cells (Tregs) (CD3+FOXP3+), CD4+ T cells (CD3+CD4+), CD8+ T cells (CD3+CD8+), macrophages (CD68+), M2 macrophages (CD68+CD163+), M1 Macrophages (CD68+ inducible nitric oxide synthase [iNOS]+), and immune checkpoints PD-1 and PD-L1. We compared the mean percentage expression of immune markers between tumor and adjacent thyroid tissue from the same patient by paired t-test and performed spatial analysis along the tumor's leading edge. Results: Immune checkpoints PD-1 and PD-L1 showed a significant increase in expression intratumorally as compared to adjacent thyroid tissue (p < 0.05). A higher trend for M2 macrophages was observed intratumorally compared to adjacent tissue. Along the leading edge, PD-L1 expression correlated negatively with CD45 and positively with CD163 intratumorally. On exploratory analysis, there was a nonsignificant trend for higher FOXP3 but less CD8 and iNOS expression in tumor from DTC with (n = 3) versus without distant metastases (n = 14). There was a nonsignificant trend for higher CD58 and iNOS expression in DTC with (n = 7) than without thyroiditis (n = 10). Conclusions: Higher tumoral PD-1 and PD-L1 expression indicate their role in DTC occurrence. A trend for more Tregs and M2 macrophages but less M1 macrophages intratumorally in patients with distant metastatic DTC, suggests their potential role as prognostic biomarkers. Future studies with larger sample sizes are needed to compare various clinicopathologic severities to harness tumor microenvironment for cancer prognostication and therapy.
引用
- Kotwal A, Vance K, Hajric K, et al. Characterization of Immune Infiltrate Along the Leading Edge of Differentiated Thyroid Cancer. Thyroid. 2024. PMID: 38916182. doi:10.1089/thy.2024.0072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。